从23年的紧急医疗住院数据库中,预测长期死亡率的预测者
Richard Conway1, Declan Byrne1, Deirdre O'Riordan1
1Department of Internal Medicine, St James's Hospital, Dublin 8, Dublin, Ireland.
Irish journal of medical science
|December 4, 2025
概括
紧急医疗住院是关键事件. 出院后的长期存活率比以前认为的要好,年龄和并发症得分预测死亡率. 住院期间的血液培养也显示出更糟糕的结果.
科学领域:
- 内部医学 内部医学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 对急性紧急医疗入院管理的关注度很高.
- 释放后的长期结果数据稀少.
研究的目的:
- 分析紧急医疗住院后的长期死亡率.
- 确定出院后长期死亡率的预测因素.
主要方法:
- 对23年的 (2002-2024) 紧急入院急性医疗入院单位 (AMAU) 的分析.
- 数据与爱尔兰国家死亡登记处的数据链接,以显示出院后的死亡率.
- 后勤和考克斯回归用于确定长期死亡率的预测因素.
主要成果:
- 186,004人入院 (95,192名患者),其中14092人在医院死亡.
- 17,808人退院后死亡,总死亡人数为31,900人 (33.5%).
- 死亡率的预测因素:年龄,AISS,查尔森并发症评分和神经学MDC诊断.
- 较高的并发症得分将生存半衰期降低到50年.
- 住院期间血液培养的表现预测了更糟糕的长期结果.
结论:
- 紧急医疗入院是长期健康的哨兵事件.
- 长期生存似乎比现有文献中预测的要好.
- 识别死亡率预测因素可以为出院后的护理策略提供信息.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.5K
相关概念视频
Assumptions of Survival Analysis
375
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
375
Actuarial Approach
274
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
274
Introduction To Survival Analysis
701
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
701
Kaplan-Meier Approach
526
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
526
Comparing the Survival Analysis of Two or More Groups
525
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
525
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
